Skip to main content
Clinical Trials/NCT03939650
NCT03939650WithdrawnNot Applicable

Differential Diagnosis Assessment in Ambulatory Care With an Automated Medical History-Taking Device: A Confirmatory Pseudo-Randomized Study With Accurate Gold-standard Diagnosis

Adrien Schwitzguebel2 sites in 1 countryStarted: January 31, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Locations
2
Primary Endpoint
Accuracy of the diagnosis established by the resident physician

Study Overview

Brief Summary

Single-center, unblinded, 2:1 parallel pseudo-randomized efficacy trial.

In the intervention group only, resident physicians will be assisted by the automated medical history-taking device "Diaana" during their consultations in outpatient ambulatory unit of the Geneva University Hospital.

In both groups, the differential diagnosis of the resident physician will be compared to the gold-standard diagnosis of the senior physician.

Detailed Description

Automated medical history-taking devices (AMHTD) are emerging tools with the potential to increase the quality of medical consultations by providing physicians with an exhaustive, high-quality, standardized anamnesis and differential diagnosis. In this study, the investigators aimed to establish whether an AMHTD of interest, "Diaana", allowed the physician to establish a more precise differential diagnosis.

A single-center, unblinded, 2:1 parallel pseudo-randomized efficacy trial will be performed. A consultation follow-up is organized at 4-6 weeks, were the gold-standard diagnosis is established by the senior physician. The study will take place in the emergency outpatient unit of La Colline Hospital (Geneva, Switzerland) and include patients suffering from symptoms covered by Diaana.

Patients in the intervention group will fulfill Dianna. Then, the resident physician will read Diaana summary, perform his consultation, and fulfill case report form, including his differential diagnosis. Then, the senior physician will see the patient and establish the gold-standard diagnosis. In the control group, the residents will directly establish a differential diagnosis, without the help of Diaana.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
16 Years to 65 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients presenting to the emergency outpatient unit of La Colline hospital (Geneva, Switzerland)
  • Patients suffering from symptoms localized to the superior or inferior member, the back, hand the chest wall.

Exclusion Criteria

  • Strictly dermatologic concerns
  • Toes trauma (because the diagnosis of those conditions is generally obvious)
  • Medical condition considered as urgent
  • Inability to complete de digilatized Diaana form (sight problems, language, inability to use a tablet computer)

Outcomes

Primary Outcomes

Accuracy of the diagnosis established by the resident physician

Time Frame: At day 0

The resident physician will select up to 5 diagnose in an exhaustive list, from the most to the least relevant. The accuracy of the diagnosis established will be measured as following: * 100% if the gold-standard diagnosis is in position#1 into the resident diagnosis list * 80% if the gond-standard diagnosis is in position#2 * 60% in position #3 * 40% in position #4 * 20% in position #5 * 0% if the gold-standard diagnosis absent of the resident diagnosis list A higher percentage is considered as a better outcome.

Secondary Outcomes

  • Patient satisfaction: Likert 1-4 scale(At day 0)
  • Consultation time(At day 0)
  • Differential diagnosis established by Diaana(At day 0)

Investigators

Sponsor
Adrien Schwitzguebel
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Adrien Schwitzguebel

Medical doctor & principal investigator

Hôpital de la Providence, Switzerland

Study Sites (2)

Loading locations...

Similar Trials